Physician profile
Sureshkumar Muttath
NPI 1275599458
$10,485.99
in general payments reported to CMS, 2019-2025
48 companies · $1,514 in 2025
The $1,514 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,684 · 2020: $824 · 2021: $1,590 · 2022: $733 · 2023: $1,738 · 2024: $1,403 · 2025: $1,514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,648 · Education: $6.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,648.39 |
| Education | $6.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,286.63 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $1,127.76 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $1,005.70 | 2019-2025 | |
| Lilly USA, LLC | $755.95 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $579.32 | 2019-2025 | Verquvo, Capvaxive, Gardasil 9 |
| Glaxosmithkline, LLC. | $573.16 | 2019-2025 | Trelegy Ellipta, Shingrix, Bexsero |
| Abbvie INC. | $527.92 | 2020-2025 | |
| Corcept Therapeutics | $485.20 | 2023-2025 | Korlym |
| Amgen INC. | $409.11 | 2019-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $322.78 | 2019-2025 | Jardiance |
| Arbor Pharmaceuticals, INC. | $299.50 | 2019-2021 | |
| Mylan Specialty L.P. | $270.47 | 2019-2024 | Yupelri |
| Kowa Pharmaceuticals America, INC. | $234.82 | 2019-2023 | Seglentis |
| Amarin Pharma, INC. | $212.11 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $197.75 | 2019-2024 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sureshkumar Muttath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.